Terça-feira, 3 de Junho de 2008

Pirfenidone

"BRISBANE, Calif., May 19 /PRNewswire-FirstCall/ -- InterMune, Inc.


(Nasdaq: ITMN) today announced that its program for the development of pirfenidone for the treatment of idiopathic pulmonary fibrosis (IPF) has received "Fast Track" designation from the U.S. Food and Drug Administration (FDA). Fast Track is a designation that the FDA reserves for a drug intended to treat a serious or life threatening condition and one that demonstrates the potential to address an unmet medical need for the condition. The FDA takes appropriate actions to facilitate the development and expedite the review of the approval applications for fast track products...."
www.intermune.com.
SOURCE  InterMune, Inc.
 

in Reuters

Etiquetas:
publicado por CH às 20:57
link do post | comentar | favorito
|
blogs SAPO

.Visitas

Free Hit Counters
Free Counter

.Subscrever por e-mail

A subscrição é anónima e gera, no máximo, um e-mail por dia.

.posts recentes

. Pirfenidone

.Mais informação

.subscrever feeds

.mais sobre mim

.Etiquetas

. cirrose

. cirrose hepática kitocel pirfenidone

. colchicina cirrose fibrose

. diabetes insulina cirrose

. encefalopatia hepática

. encefalopatia hepática rifaximina

. endoscopia

. estágios cirrose

. esteatose hepática

. fígado

. gastropatia hipertensiva portal

. kitocel

. meld

. pirfenidone

. plaquetas

. rifaximina

. rifaximina xifaxan encefalopatia hepatic

. rifaximina xifaxan/flonorm

. rtp

. transaminases

. varizes

. varizes encefalopatia

. varizes esofágicas

. vitamina

. todas as tags

.A ter conhecimento...

online

.Pelo Mundo

free counters